Mitsugu Fujita, M.D., Ph.D., and Ryo Ueda, M.D., Ph.D., both researchers with the University of Pittsburgh Cancer Institute’s (UPCI) Brain Tumor Program, are pursuing the same aim: understanding the body’s immune system in order to fight the deadliest and most common form of brain cancer. At the American Association for Cancer Research (AACR) Annual Meeting, April 12 to 16, in San Diego, they will present research discussing their novel approaches to achieving this goal. Dr.